nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
|
Fisher, Jonathan |
|
2017 |
25 |
5 |
p. 1234-1247 14 p. |
artikel |
2 |
CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma
|
Xing, Yue |
|
2017 |
25 |
5 |
p. 1209-1221 13 p. |
artikel |
3 |
Cardiovascular Gene Therapy: Past, Present, and Future
|
Ylä-Herttuala, Seppo |
|
2017 |
25 |
5 |
p. 1095-1106 12 p. |
artikel |
4 |
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
|
Rivière, Isabelle |
|
2017 |
25 |
5 |
p. 1117-1124 8 p. |
artikel |
5 |
Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α
|
Kishnani, Priya |
|
2017 |
25 |
5 |
p. 1199-1208 10 p. |
artikel |
6 |
Evolving Gene Therapy in Primary Immunodeficiency
|
Thrasher, Adrian J. |
|
2017 |
25 |
5 |
p. 1132-1141 10 p. |
artikel |
7 |
Excision of Latent HIV-1 from Infected Cells In Vivo: An Important Step Forward
|
De Silva Feelixge, Harshana S. |
|
2017 |
25 |
5 |
p. 1062-1064 3 p. |
artikel |
8 |
FDA-Approved Oligonucleotide Therapies in 2017
|
Stein, Cy A. |
|
2017 |
25 |
5 |
p. 1069-1075 7 p. |
artikel |
9 |
Gene Therapy for β-Hemoglobinopathies
|
Cavazzana, Marina |
|
2017 |
25 |
5 |
p. 1142-1154 13 p. |
artikel |
10 |
Gene Therapy for Hemophilia
|
Nienhuis, Arthur W. |
|
2017 |
25 |
5 |
p. 1163-1167 5 p. |
artikel |
11 |
Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
|
Biffi, Alessandra |
|
2017 |
25 |
5 |
p. 1155-1162 8 p. |
artikel |
12 |
In This Issue
|
|
|
2017 |
25 |
5 |
p. 1059- 1 p. |
artikel |
13 |
In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
|
Yin, Chaoran |
|
2017 |
25 |
5 |
p. 1168-1186 19 p. |
artikel |
14 |
Oncolytic Virotherapy: A Contest between Apples and Oranges
|
Russell, Stephen J. |
|
2017 |
25 |
5 |
p. 1107-1116 10 p. |
artikel |
15 |
Perspectives on Manufacturing of High-Quality Cell Therapies
|
Rivière, Isabelle |
|
2017 |
25 |
5 |
p. 1067-1068 2 p. |
artikel |
16 |
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers
|
Zhang, Chengcheng |
|
2017 |
25 |
5 |
p. 1248-1258 11 p. |
artikel |
17 |
Progress toward Gene Therapy for Duchenne Muscular Dystrophy
|
Chamberlain, Joel R. |
|
2017 |
25 |
5 |
p. 1125-1131 7 p. |
artikel |
18 |
Research Highlights
|
|
|
2017 |
25 |
5 |
p. 1060-1061 2 p. |
artikel |
19 |
Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice
|
Hu, Zhidong |
|
2017 |
25 |
5 |
p. 1222-1233 12 p. |
artikel |
20 |
Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?
|
Parihar, Robin |
|
2017 |
25 |
5 |
p. 1064-1066 3 p. |
artikel |
21 |
Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals
|
Lu, Jiamiao |
|
2017 |
25 |
5 |
p. 1187-1198 12 p. |
artikel |
22 |
Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward
|
Bennett, Jean |
|
2017 |
25 |
5 |
p. 1076-1094 19 p. |
artikel |
23 |
Two Decades of ASGCT: Dreams Become Reality
|
Dunbar, Cynthia E. |
|
2017 |
25 |
5 |
p. 1057-1058 2 p. |
artikel |